作者观点:
创新研报 | 自主创新,数智赋能-2023中国医药健康明日之星项目报告
Alexander Li
+ 关注
德勤中国举办的2023中国医药健康明日之星评选项目旨在表彰在医药健康细分领域处于领先地位并具备巨大成长潜力的优秀企业。该榜单包括邦泰生物、凡星医疗、华龛生物、立康生命等多家企业,集中在一线和新一线城市,尤其集聚在上海和北京,行业聚焦在新药研发和医疗器械两大领域。
There was a problem reporting this post.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.